Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Non-Current Debt (2020 - 2022)

Acro Biomedical (ACBM) has 3 years of Non-Current Debt data on record, last reported at $78826.0 in Q4 2022.

  • For Q4 2022, Non-Current Debt rose 280.05% year-over-year to $78826.0; the TTM value through Dec 2022 reached $78826.0, up 280.05%, while the annual FY2022 figure was $78826.0, 280.05% up from the prior year.
  • Non-Current Debt reached $78826.0 in Q4 2022 per ACBM's latest filing, up from $20741.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $242951.0 in Q4 2020 and bottomed at $20741.0 in Q4 2021.
  • Average Non-Current Debt over 3 years is $114172.7, with a median of $78826.0 recorded in 2022.
  • Peak YoY movement for Non-Current Debt: plummeted 91.46% in 2021, then skyrocketed 280.05% in 2022.
  • A 3-year view of Non-Current Debt shows it stood at $242951.0 in 2020, then tumbled by 91.46% to $20741.0 in 2021, then surged by 280.05% to $78826.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $78826.0 in Q4 2022, $20741.0 in Q4 2021, and $242951.0 in Q4 2020.